表紙
市場調査レポート

Colby Pharmaceutical Company :製品パイプライン分析

Colby Pharmaceutical Company - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 251681
出版日 ページ情報 英文 28 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
Colby Pharmaceutical Company :製品パイプライン分析 Colby Pharmaceutical Company - Product Pipeline Review - 2015
出版日: 2015年06月17日 ページ情報: 英文 28 Pages
概要

Colby Pharmaceutical Company は、癌や感染症、炎症性疾患、疼痛などの治療のための生物学的製剤および小分子薬を製造する製薬会社です。

当レポートでは、Colby Pharmaceutical Company における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Colby Pharmaceutical Companyの基本情報

  • Colby Pharmaceutical Companyの概要
  • 主要情報
  • 企業情報

Colby Pharmaceutical Company :R&Dの概要

  • 主な治療範囲

Colby Pharmaceutical Company :パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • 併用療法モダリティ

Colby Pharmaceutical Company :パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

Colby Pharmaceutical Company :開発段階が不明のパイプライン製品

  • 開発段階が不明の製品/併用療法モダリティ

Colby Pharmaceutical Company :薬剤プロファイル

  • CPC-1001
  • JVRS-100
  • CPC-410
  • JVRS-100 + Herpes Simplex Virus-2 Vaccine
  • JVRS-100 + Universal Influenza Vaccine
  • JVRSOD
  • JVRS-100 + HBV Vaccine
  • JVRS-100 + Malaria Vaccine
  • CPC-507
  • CPC-703

Colby Pharmaceutical Company :パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Colby Pharmaceutical Company :最近のパイプライン動向

Colby Pharmaceutical Company :休止中のプロジェクト

Colby Pharmaceutical Company :本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07180CDB

Summary

Global Markets Direct's, 'Colby Pharmaceutical Company - Product Pipeline Review - 2015', provides an overview of the Colby Pharmaceutical Company's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Colby Pharmaceutical Company's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Colby Pharmaceutical Company including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Colby Pharmaceutical Company's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Colby Pharmaceutical Company's pipeline products

Reasons to buy

  • Evaluate Colby Pharmaceutical Company's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Colby Pharmaceutical Company in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Colby Pharmaceutical Company's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Colby Pharmaceutical Company and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Colby Pharmaceutical Company
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Colby Pharmaceutical Company and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Colby Pharmaceutical Company Snapshot
    • Colby Pharmaceutical Company Overview
    • Key Information
    • Key Facts
  • Colby Pharmaceutical Company - Research and Development Overview
    • Key Therapeutic Areas
  • Colby Pharmaceutical Company - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Colby Pharmaceutical Company - Pipeline Products Glance
    • Colby Pharmaceutical Company - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Colby Pharmaceutical Company - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
    • Colby Pharmaceutical Company - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Colby Pharmaceutical Company - Drug Profiles
    • CPC-551
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • JVRS-100
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • JVRSOD
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Prostate Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CPC-123
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Colby Pharmaceutical Company - Pipeline Analysis
    • Colby Pharmaceutical Company - Pipeline Products by Target
    • Colby Pharmaceutical Company - Pipeline Products by Route of Administration
    • Colby Pharmaceutical Company - Pipeline Products by Molecule Type
    • Colby Pharmaceutical Company - Pipeline Products by Mechanism of Action
  • Colby Pharmaceutical Company - Recent Pipeline Updates
  • Colby Pharmaceutical Company - Dormant Projects
  • Colby Pharmaceutical Company - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Colby Pharmaceutical Company, Key Information
  • Colby Pharmaceutical Company, Key Facts
  • Colby Pharmaceutical Company - Pipeline by Indication, 2015
  • Colby Pharmaceutical Company - Pipeline by Stage of Development, 2015
  • Colby Pharmaceutical Company - Monotherapy Products in Pipeline, 2015
  • Colby Pharmaceutical Company - Phase II, 2015
  • Colby Pharmaceutical Company - Phase I, 2015
  • Colby Pharmaceutical Company - Preclinical, 2015
  • Colby Pharmaceutical Company - Unknown, 2015
  • Colby Pharmaceutical Company - Pipeline by Target, 2015
  • Colby Pharmaceutical Company - Pipeline by Route of Administration, 2015
  • Colby Pharmaceutical Company - Pipeline by Molecule Type, 2015
  • Colby Pharmaceutical Company - Pipeline Products by Mechanism of Action, 2015
  • Colby Pharmaceutical Company - Recent Pipeline Updates, 2015
  • Colby Pharmaceutical Company - Dormant Developmental Projects,2015
  • Colby Pharmaceutical Company, Subsidiaries

List of Figures

  • Colby Pharmaceutical Company - Pipeline by Top 10 Indication, 2015
  • Colby Pharmaceutical Company - Pipeline by Stage of Development, 2015
  • Colby Pharmaceutical Company - Monotherapy Products in Pipeline, 2015
  • Colby Pharmaceutical Company - Pipeline by Top 10 Target, 2015
  • Colby Pharmaceutical Company - Pipeline by Top 10 Route of Administration, 2015
  • Colby Pharmaceutical Company - Pipeline by Top 10 Molecule Type, 2015
  • Colby Pharmaceutical Company - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top